Ratings by Freedom Broker (Ilya Zubkov)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/26/2026 | Electromed | ELMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2026 | Candel Therapeutics Inc. | CADL | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2026 | Sionna Therapeutics | SION | Downgrade | Hold (Buy) |
4.50 (3.60) |
-20% | Details | |
| 8/10/2026 | Blue Foundry Bancorp | BLFY | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2026 | VieMed Healthcare Inc. | VMD | Downgrade | Hold (Buy) |
9.84 (9.80) |
-0.41% | Details | |
| 8/5/2026 | Illumina | ILMN | Downgrade | Hold (Buy) |
203.01 (269.42) |
32.71% | Details | |
| 8/3/2026 | Sanara MedTech | SMTI | Downgrade | Hold (Buy) |
33.86 (32.80) |
-3.13% | Details | |
| 7/15/2026 | AngioDynamics | ANGO | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2026 | Niagen Bioscience | NAGE | New Coverage | Buy (N/A) |
3.43 (2.43) |
-29.15% | Details | |
| 6/17/2026 | Sanara MedTech | SMTI | New Coverage | Buy (N/A) |
22.69 (32.80) |
44.56% | Details | |
| 5/18/2026 | Atara Biotherapeutics | ATRA | Upgrade | Hold (Sell) |
9.58 (8.59) |
-10.33% | Details | |
| 5/11/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2026 | Amgen | AMGN | Upgrade | Buy (Hold) |
331.11 (439.26) |
32.66% | Details | |
| 5/1/2026 | Biogen | BIIB | Upgrade | Buy (Hold) |
189.28 (250.69) |
32.44% | Details | |
| 4/20/2026 | Johnson & Johnson | JNJ | Maintain | Hold (N/A) |
|
Details | ||
| 4/6/2026 | Inogen, Inc | INGN | New Coverage | Buy (N/A) |
6.21 (7.10) |
14.33% | Details | |
| 4/6/2026 | GoHealth Inc. | GOCO | Downgrade | Hold (Buy) |
1.27 (0.31) |
-75.59% | Details | |
| 4/6/2026 | AngioDynamics | ANGO | New Coverage | Buy (N/A) |
10.31 (12.37) |
19.98% | Details | |
| 4/2/2026 | IRadimed Corp | IRMD | New Coverage | Buy (N/A) |
96.54 (85.82) |
-11.1% | Details |
